EuroMedLab 2019
The 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine
At EuroMedLab 2019, visitors to our booth explored the latest innovations in clinical chemistry and laboratory medicine. Check out research posters published at the event and find more information on the solutions we showcased.
Poster Access AMH Assay Results Reinforce Importance of Population-specific Reference Intervals
Evaluate the results from a study of age-specific reference intervals (RIs) for anti-Müllerian hormone (AMH) levels in Russian women and men, which was showcased at EuroMedLab 2019. See how the newly derived RIs compare to those provided by the Access AMH assay manufacturer, which also includes Brazilian study data. These results reinforce the importance of obtaining population-specific RIs for each country.
DownloadPoster Analytical Performance Characteristics of Access PCT
Review the evidence demonstrating strong correlation and concordance of the Access PCT immunoassay to a well-established PCT predicate method. Showcased at EuroMedLab 2019, this clinical laboratory study confirms the precision and reproducibility of Access PCT assay results, which are returned within 20 minutes.
DownloadPoster Access AMH Assay Reveals Temperatures Don’t Alter Anti-Müllerian Hormone Stability
Review the study results revealed at EuroMedLab 2019 that show how broad temperature ranges produce no significant anti-Müllerian hormone (AMH) changes. This poster illustrates how one-to-five freeze-thaw cycles, four different temperature levels and multiple fresh-to-frozen storage conditions didn’t alter the molecule’s stability; which demonstrates the high sensitivity and precision of the Access AMH assay across diverse environments.
DownloadElevate Your Performance and Advance Patient Care
Visitors to our booth at EuroMedLab 2019 were able to network and hear from peers and scientific experts on cutting-edge industry topics. They:
- Received an in-depth view of how the innovative DxA 5000* total laboratory automation system delivers unparalleled rapid and consistent turnaround times, provides a new level of comprehensive preanalytical sample-quality detection and significantly reduces the number of manual processing steps to improve laboratory efficiency
- Learned how laboratories can empower clinical staff in identifying prevalent and costly health risks sooner with solutions like the Early Sepsis Indicator
- Identified ways to save time, increase productivity and deliver greater insights with the DxONE clinical informatics portfolio
Our Scientific Workshops at EuroMedLab
Visitors to our scientific workshops saw for themselves the future of clinical chemistry and laboratory medicine. They discovered how to:
- Reduce manual steps and help improve quality with the help of clinical information management tools
- Accelerate patient care by delivering rapid and consistent results efficiently through automation technology
- Identify sepsis―which affects more than 30 million patients worldwide1―sooner
*Pending clearance by the United States Food and Drug Administration; not yet available for in vitro diagnostic use in the U.S. For Investigational Use Only. The performance characteristics of this product have not been established.
1Sepsis Alliance. “Critical Fact Sheet.” Sepsis.org. Accessed January 15, 2018.